This is a preview of subscription content, log in via an institution to check access.
Notes
Funded by Genentech Inc and F. Hoffmann-La Roche.
Reference
Fischer A, et al. All-cause Healthcare Costs and Mortality in Patients with Systemic Sclerosis with Lung Involvement. The Journal of Rheumatology : 15 Nov 2017
Rights and permissions
About this article
Cite this article
Lung involvement raises costs for systemic sclerosis patients. PharmacoEcon Outcomes News 792, 16 (2017). https://doi.org/10.1007/s40274-017-4539-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4539-x